ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Elevance Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026
$430.23+1.97 (+0.46%)
Close on Oct 19, 2026
- Market cap
- $93.75B
- P/E (TTM)
- 19.1
- Dividend yield
- –
Elevance Health, Inc. revenue by segment
By business segment
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reportable Segments | $5.45B | $6.12B | $7.20B | $7.56B | $7.68B | $8.02B | $7.86B | – | – | – | – | – | -29.0% |
| Health Benefits | $3.43B | $4.10B | $4.16B | $4.59B | $5.59B | $6.17B | $6.24B | $6.80B | $7.03B | $7.03B | $6.89B | $6.88B | -38.5% |
| Total Carelon | $3.35B | $3.34B | $3.38B | $3.37B | $3.40B | $3.17B | $2.89B | – | – | – | – | – | -1.5% |
| CarelonRx | $2.44B | $2.40B | $2.42B | $2.23B | $2.29B | $2.25B | $2.17B | $2.13B | $1.99B | $1.99B | $1.98B | $1.96B | +6.7% |
| Carelon Services | $905.00M | $939.00M | $960.00M | $1.15B | $1.11B | $918.00M | $717.00M | $784.00M | $792.00M | $741.00M | $680.00M | $675.00M | -18.5% |
| Corporate & Other | -$1.33B | -$1.32B | -$337.00M | -$394.00M | -$1.31B | -$1.33B | -$1.27B | -$1.24B | -$991.00M | -$1.07B | -$1.04B | – | +1.4% |
| Segment Eliminations [Member] | – | – | – | – | – | – | – | – | – | – | $0 | $0 | – |
| Corporate & Other Segment | – | – | – | – | – | – | – | – | – | – | -$1.04B | -$1.01B | – |
| Total | – | – | – | – | – | – | – | $2.91B | $2.78B | $2.73B | $2.66B | $2.64B | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | $25.11B | $24.89B | $24.47B | $24.72B | $24.45B | $23.94B | $22.63B | $21.31B | $20.60B | $19.93B | $19.45B | – | 12.5% | +2.7% |
| Service fees | $8.83B | $8.65B | $8.48B | $8.34B | $8.23B | $8.40B | $8.41B | $8.30B | $8.32B | $7.97B | $7.90B | – | 4.4% | +7.2% |
By region
From the segment and revenue-disaggregation notes of Elevance Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.